Srivastava Aneesh, Prabhakaran Sandeep, Sureka Sanjoy Kumar, Kapoor Rakesh, Kumar Anant, Sharma R K, Prasad Narayan, Ansari M S
Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Max Superspeciality Hospital, Delhi, India.
Indian J Urol. 2015 Jan-Mar;31(1):33-7. doi: 10.4103/0970-1591.145290.
Renal transplantation is the treatment of choice for children with end-stage renal disease (ESRD). We evaluated the outcome of renal transplantation in the pediatric and adolescent age groups in the perspective of a developing country as compared with developed nations while highlighting the challenges we have faced in a pediatric transplant programme.
Seventy live related pediatric and adolescent renal transplantations were reviewed retrospectively. Variables analyzed were etiology of ESRD, pre-transplant renal replacement modality, donor relationship, surgical complications, rejection episodes, immuno-suppression regimens, compliance to immunosuppression, graft survival and overall survival.
The cohort consisted of 13 (18%) female and 57 male (82%) recipients. The mean age was 14 ± 1.4 years. The etiology of ESRD was chronic glomerulonephritis (n = 43), chronic interstitial nephritis (n = 26) and Alport's syndrome (n = 1). Fifty-six (80%) children were on hemo-dialysis and 10 (14%) on peritoneal dialysis prior to transplantation. 80.5% and 61% patients were strictly compliant to immunosuppresant medications at 1 and 5 years. The 1, 3 and 5 year graft survival rates were 94.3%, 89.2% and 66.8%, respectively. The overall survival rates were 95.7%, 96.4% and 94.1% for 1, 3 and 5 years, respectively.
The spectrum of etiology of ESRD differs in our patients from the west, with chronic glomerulonephritis being the most common etiology. Early graft survival is comparable, but the 5-year graft survival is clearly inferior as compared with developed countries.
肾移植是终末期肾病(ESRD)患儿的首选治疗方法。我们从一个发展中国家的角度评估了儿童和青少年年龄组肾移植的结果,并与发达国家进行了比较,同时强调了我们在儿科移植项目中面临的挑战。
回顾性分析70例活体亲属供肾的儿童和青少年肾移植病例。分析的变量包括ESRD的病因、移植前的肾脏替代治疗方式、供体关系、手术并发症、排斥反应、免疫抑制方案、免疫抑制的依从性、移植物存活率和总存活率。
该队列包括13名(18%)女性和57名男性(82%)受者。平均年龄为14±1.4岁。ESRD的病因是慢性肾小球肾炎(n = 43)、慢性间质性肾炎(n = 26)和Alport综合征(n = 1)。56名(80%)儿童在移植前接受血液透析,10名(14%)接受腹膜透析。1年和5年时分别有80.5%和61%的患者严格遵守免疫抑制药物治疗。1年、3年和5年的移植物存活率分别为94.3%、89.2%和66.8%。1年、3年和5年的总存活率分别为95.7%、96.4%和94.1%。
我们患者中ESRD的病因谱与西方不同,慢性肾小球肾炎是最常见的病因。早期移植物存活率相当,但与发达国家相比,5年移植物存活率明显较低。